YK11 YK-11 CAS: 1370003-76-1

CAS NO: 1370003-76-1
YK11 YK-11
Chemical Name: yk11
Molecular Formula: C25H34O6
Formula Weight: 430.53
CAS No.: 1370003-76-1
Description Review
Description

YK11, also known as YK-11, is a synthetic steroid and selective androgen receptor modulator (SARM) that has gained popularity in the bodybuilding community for its potential muscle-building effects.

Chemical Name:

The chemical name for YK11 is (17a,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester.

Molecular Formula:

The molecular formula for YK11 is C25H34O6, indicating that it contains 25 carbon atoms, 34 hydrogen atoms, and 6 oxygen atoms.

Formula Weight:

The molecular weight of YK11 is 430.54 g/mol.

CAS No:

The CAS number for YK11 is 1370003-76-1.

Top Ten Keywords from Google and Synonyms:

  1. YK11
  2. SARM
  3. Selective Androgen Receptor Modulator
  4. Bodybuilding
  5. Muscle Building
  6. Anabolic Steroid
  7. Muscle Growth
  8. Performance Enhancement
  9. Testosterone Replacement Therapy
  10. Pharmacology

Health Benefits of this Product:

YK11 is primarily used by bodybuilders and athletes to increase muscle mass and strength. It may also have potential benefits for those with muscle-wasting conditions such as muscular dystrophy.

Potential Effects:

As a SARM, YK11 binds selectively to androgen receptors in the body and stimulates muscle growth. It may also increase bone density and improve overall physical performance.

Product Mechanism:

YK11 works by binding to and activating the androgen receptor in muscle cells, which leads to an increase in protein synthesis and muscle growth. Unlike traditional steroids, YK11 is believed to be selective in its actions, meaning that it does not affect other tissues in the body as significantly.

Safety:

There is limited research available on the safety of YK11, particularly in humans. As with any supplement or medication, it is important to speak with a healthcare provider before using YK11 if you have any underlying medical conditions or are taking any medications.

Side Effects:

Common side effects associated with YK11 use include acne, hair loss, and increased aggression. More serious side effects such as liver damage may occur, although these are rare.

Dosing Information:

There is no established dosing information for YK11 at this time. However, it is typically used in cycles of several weeks at a time, followed by a break to allow the body to recover.

Conclusion:

YK11 is a synthetic steroid and SARM that is primarily used by bodybuilders and athletes to increase muscle mass and strength. While promising, there is currently limited research available on the safety and effectiveness of YK11. As with any supplement or medication, it is important to speak with a healthcare provider before using YK11 if you have any underlying medical conditions or are taking any medications. With further research, YK11 may become an important tool in the treatment of muscle-wasting conditions such as muscular dystrophy, as well as a popular option for those looking to enhance their athletic performance.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us